{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:54:46Z","timestamp":1789206886190,"version":"build-2803163510"},"reference-count":291,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.cjca.2011.02.005","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T17:21:37Z","timestamp":1306344097000},"page":"265-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Targeted Gene Therapy for the Treatment of Heart Failure"],"prefix":"10.1016","volume":"27","author":[{"given":"Kleopatra","family":"Rapti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine H.","family":"Chaanine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Hajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2011.02.005_bib1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","article-title":"Heart disease and stroke statistics\u20142009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/CIRCHEARTFAILURE.108.814459","article-title":"Large animal models of heart failure: a critical link in the translation of basic science to clinical practice","volume":"2","author":"Dixon","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2011.02.005_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2459\/JCM.0b013e328339d884","article-title":"Pharmacological treatment of chronic systolic heart failure: are we scraping the bottom of the barrel?","volume":"11","author":"Abate","year":"2010","journal-title":"J Cardiovasc Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4065\/mcp.2009.0494","article-title":"Chronic heart failure: contemporary diagnosis and management","volume":"85","author":"Ramani","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2011.02.005_bib5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jacc.2009.04.020","article-title":"The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease","volume":"54","author":"Lamour","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.healun.2008.05.006","article-title":"Long-term outcomes of heart transplantation in older recipients","volume":"27","author":"Marelli","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cjca.2011.02.005_bib8","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1152\/physrev.00039.2007","article-title":"Designing heart performance by gene transfer","volume":"88","author":"Davis","year":"2008","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjca.2011.02.005_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/hrt.2007.116483","article-title":"Gene therapy: targeting the myocardium","volume":"94","author":"Lyon","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2011.02.005_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1089\/hum.2009.164","article-title":"Cardiac gene therapy: optimization of gene delivery techniques in vivo","volume":"21","author":"Katz","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib11","doi-asserted-by":"crossref","first-page":"S432","DOI":"10.1054\/jcaf.2002.129284","article-title":"From mouse to man: understanding heart failure through genetically altered mouse models","volume":"8","author":"Chu","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2011.02.005_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2007.01.003","article-title":"Rodent models of heart failure","volume":"56","author":"Balakumar","year":"2007","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.cjca.2011.02.005_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1517\/14712590903321462","article-title":"Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure","volume":"10","author":"Lipskaia","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJM199008303230904","article-title":"Gene transfer into humans\u2014immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction","volume":"323","author":"Rosenberg","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0140-6736(96)03361-2","article-title":"Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb","volume":"348","author":"Isner","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2011.02.005_bib16","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/01.CIR.97.7.645","article-title":"Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease","volume":"97","author":"Schumacher","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1517\/14712598.8.7.911","article-title":"Optimizing gene delivery vectors for the treatment of heart disease","volume":"8","author":"Gray","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib19","first-page":"1","article-title":"Recent Advances in Non-viral Gene Delivery","volume":"53PA","author":"Conwell","year":"2005","journal-title":"Adv Genet"},{"key":"10.1016\/j.cjca.2011.02.005_bib20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/sj.gt.3301923","article-title":"Gene therapy progress and prospects: nonviral vectors","volume":"9","author":"Niidome","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib21","doi-asserted-by":"crossref","first-page":"23018","DOI":"10.1074\/jbc.M010873200","article-title":"An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy","volume":"276","author":"Bigger","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cjca.2011.02.005_bib22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-59745-561-9_4","article-title":"Use of minicircle plasmids for gene therapy","volume":"542","author":"Mayrhofer","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cjca.2011.02.005_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1474-4422(03)00382-X","article-title":"Novel therapies for Duchenne muscular dystrophy","volume":"2","author":"Kapsa","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.cjca.2011.02.005_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12033-007-0028-y","article-title":"On the stability of plasmid DNA vectors during cell culture and purification","volume":"36","author":"Freitas","year":"2007","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.cjca.2011.02.005_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cardiores.2005.12.017","article-title":"Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors","volume":"70","author":"Muller","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jconrel.2003.08.004","article-title":"Extracellular and intracellular barriers in non-viral gene delivery","volume":"93","author":"Ruponen","year":"2003","journal-title":"J Control Release"},{"key":"10.1016\/j.cjca.2011.02.005_bib27","first-page":"315","article-title":"Nonviral gene delivery methods in cardiovascular diseases","volume":"108","author":"Ruponen","year":"2005","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.molmed.2005.03.008","article-title":"Genetic therapies for cardiovascular diseases","volume":"11","author":"Melo","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12033-007-0021-5","article-title":"Adenoviral vectors for gene therapy","volume":"36","author":"Douglas","year":"2007","journal-title":"Mol Biotechnol"},{"key":"10.1016\/j.cjca.2011.02.005_bib30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/MMBR.63.3.725-734.1999","article-title":"Role of alpha(v) integrins in adenovirus cell entry and gene delivery","volume":"63","author":"Nemerow","year":"1999","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.cjca.2011.02.005_bib31","doi-asserted-by":"crossref","first-page":"13062","DOI":"10.1128\/JVI.77.24.13062-13072.2003","article-title":"Reduction of natural adenovirus tropism to mouse liver by fiber-shaft exchange in combination with both CAR- and alphav integrin-binding ablation","volume":"77","author":"Koizumi","year":"2003","journal-title":"J Virol"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2011.02.005_bib32","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1002\/jgm.496","article-title":"Adenoviral vectors for gene transfer and therapy","volume":"6","author":"Volpers","year":"2004","journal-title":"J Gene Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1162\/1535350041464847","article-title":"Cardiac-specific gene expression facilitated by an enhanced myosin light chain promoter","volume":"3","author":"Boecker","year":"2004","journal-title":"Mol Imaging"},{"key":"10.1016\/j.cjca.2011.02.005_bib34","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/hc0802.105564","article-title":"Targeting phospholamban by gene transfer in human heart failure","volume":"105","author":"del Monte","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib35","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/hc3601.095574","article-title":"Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure","volume":"104","author":"del Monte","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib36","first-page":"295","article-title":"An update on angiogenic gene therapy: vascular endothelial growth factor and other directions","volume":"8","author":"Yla-Herttuala","year":"2006","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2009.02.002","article-title":"Public trust and research a decade later: what have we learned since Jesse Gelsinger's death?","volume":"97","author":"Yarborough","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cjca.2011.02.005_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymgme.2008.12.016","article-title":"Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency","volume":"96","author":"Wilson","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cjca.2011.02.005_bib39","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/gt.2009.148","article-title":"Progress and prospects: immune responses to viral vectors","volume":"17","author":"Nayak","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib40","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/sj.gt.3302037","article-title":"Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy","volume":"10","author":"Jooss","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib42","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1073\/pnas.91.10.4407","article-title":"Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy","volume":"91","author":"Yang","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0958-1669(99)00007-5","article-title":"Adenovirus vectors for gene delivery","volume":"10","author":"Benihoud","year":"1999","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.cjca.2011.02.005_bib44","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1128\/JVI.75.11.5222-5229.2001","article-title":"Biology of E1-deleted adenovirus vectors in nonhuman primate muscle","volume":"75","author":"Zoltick","year":"2001","journal-title":"J Virol"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2011.02.005_bib45","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1038\/sj.gt.3302612","article-title":"Gutless adenovirus: last-generation adenovirus for gene therapy","volume":"12","author":"Alba","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1128\/JVI.80.1.27-37.2006","article-title":"Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses","volume":"80","author":"Xiong","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib47","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1038\/sj.mt.6300305","article-title":"One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications","volume":"15","author":"Barcia","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2174\/156652307782151498","article-title":"Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions","volume":"7","author":"Lowenstein","year":"2007","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib49","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1126\/science.8493571","article-title":"How does HIV cause AIDS?","volume":"260","author":"Weiss","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cjca.2011.02.005_bib50","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1128\/JVI.72.10.8150-8157.1998","article-title":"Development of a self-inactivating lentivirus vector","volume":"72","author":"Miyoshi","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2174\/1566523054546224","article-title":"Altering the tropism of lentiviral vectors through pseudotyping","volume":"5","author":"Cronin","year":"2005","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib52","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.gt.3301552","article-title":"Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors","volume":"8","author":"Peng","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib53","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1128\/JVI.73.1.576-584.1999","article-title":"A packaging cell line for lentivirus vectors","volume":"73","author":"Kafri","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib54","first-page":"43","article-title":"Small- to large-scale production of lentivirus vectors","volume":"229","author":"Marino","year":"2003","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cjca.2011.02.005_bib55","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/156652309790031120","article-title":"State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations","volume":"9","author":"Pauwels","year":"2009","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib56","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/sj.gt.3301936","article-title":"\u2018Advanced\u2019 generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo","volume":"10","author":"Bonci","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib57","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/jgm.431","article-title":"Efficient gene transfer of a simian immuno-deficiency viral vector into cardiomyocytes derived from primate embryonic stem cells","volume":"5","author":"Nagata","year":"2003","journal-title":"J Gene Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib58","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/CIRCULATIONAHA.105.588954","article-title":"In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery","volume":"113","author":"Cao","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib59","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.gt.3303017","article-title":"A lentiviral vector with a short troponin-I promoter for tracking cardiomyocyte differentiation of human embryonic stem cells","volume":"15","author":"Gallo","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib60","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1097\/01.TP.0000131174.52424.4A","article-title":"Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts","volume":"77","author":"Kearns-Jonker","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2011.02.005_bib61","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1038\/sj.gt.3302547","article-title":"Lentivirus-mediated gene transfer of viral interleukin-10 delays but does not prevent cardiac allograft rejection","volume":"12","author":"Zhao","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.tp.0000194859.98504.9e","article-title":"Lentiviral gene transfer of the chemokine antagonist RANTES 9-68 prolongs heart graft survival","volume":"81","author":"Vassalli","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cjca.2011.02.005_bib63","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1161\/01.CIR.0000065598.46411.EF","article-title":"Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo","volume":"107","author":"Fleury","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib64","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00395-002-0360-0","article-title":"Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo","volume":"97","author":"Zhao","year":"2002","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib65","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1253\/circj.70.1503","article-title":"Correction of cardiac abnormalities in fabry mice by direct intraventricular injection of a recombinant lentiviral vector that engineers expression of alpha-galactosidase A","volume":"70","author":"Yoshimitsu","year":"2006","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2011.02.005_bib66","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/mt.2008.244","article-title":"Direct injection of kit ligand-2 lentivirus improves cardiac repair and rescues mice post-myocardial infarction","volume":"17","author":"Higuchi","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib67","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/mt.2008.61","article-title":"Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats","volume":"16","author":"Niwano","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib68","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1126\/science.149.3685.754","article-title":"Adenovirus-Associated Defective Virus Particles","volume":"149","author":"Atchison","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.cjca.2011.02.005_bib69","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1073\/pnas.55.6.1467","article-title":"Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics","volume":"55","author":"Hoggan","year":"1966","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib70","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/oxfordjournals.aje.a120897","article-title":"Epidemiology of adenovirus-associated virus infection in a nursery population","volume":"88","author":"Blacklow","year":"1968","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib71","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.ymthe.2004.09.011","article-title":"Adeno-associated virus and the development of adeno-associated virus vectors: a historical perspective","volume":"10","author":"Carter","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib72","series-title":"Fields' virology","author":"Fields","year":"2007"},{"key":"10.1016\/j.cjca.2011.02.005_bib73","series-title":"Parvoviruses","author":"Kerr","year":"2006"},{"key":"10.1016\/j.cjca.2011.02.005_bib74","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ymthe.2006.05.009","article-title":"Adeno-associated virus serotypes: vector toolkit for human gene therapy","volume":"14","author":"Wu","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib75","doi-asserted-by":"crossref","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","article-title":"Clades of Adeno-associated viruses are widely disseminated in human tissues","volume":"78","author":"Gao","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib76","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib77","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1128\/JVI.80.10.5082-5085.2006","article-title":"Identification and characterization of novel adeno-associated virus isolates in ATCC virus stocks","volume":"80","author":"Schmidt","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib78","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1128\/JVI.02012-07","article-title":"Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid- and heparan sulfate proteoglycan-independent transduction activity","volume":"82","author":"Schmidt","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib79","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virol.2006.05.023","article-title":"Adeno-associated virus (AAV) capsid genes isolated from rat and mouse liver genomic DNA define two new AAV species distantly related to AAV-5","volume":"353","author":"Lochrie","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.cjca.2011.02.005_bib80","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.virol.2004.10.012","article-title":"Two novel adeno-associated viruses from cynomolgus monkey: pseudotyping characterization of capsid protein","volume":"330","author":"Mori","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.cjca.2011.02.005_bib81","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/jgm.1205","article-title":"Recent developments in adeno-associated virus vector technology","volume":"10","author":"Buning","year":"2008","journal-title":"J Gene Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0065-2660(09)67002-4","article-title":"Adeno-associated viral vectors and their redirection to cell-type specific receptors","volume":"67","author":"Michelfelder","year":"2009","journal-title":"Adv Genet"},{"key":"10.1016\/j.cjca.2011.02.005_bib83","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/1566523054064968","article-title":"AAV hybrid serotypes: improved vectors for gene delivery","volume":"5","author":"Choi","year":"2005","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib84","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1073\/pnas.81.20.6466","article-title":"Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells","volume":"81","author":"Hermonat","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib85","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/JVI.76.2.791-801.2002","article-title":"Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity","volume":"76","author":"Rabinowitz","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib86","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1128\/jvi.71.2.941-948.1997","article-title":"A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle","volume":"71","author":"Xiao","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib87","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1073\/pnas.79.6.2077","article-title":"Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells","volume":"79","author":"Samulski","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib88","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/molmed.2009.00101","article-title":"Cellular endocytosis and gene delivery","volume":"16","author":"Ziello","year":"2010","journal-title":"Mol Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib89","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1128\/JVI.77.8.4751-4759.2003","article-title":"Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue","volume":"77","author":"Duan","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib90","doi-asserted-by":"crossref","first-page":"9468","DOI":"10.1128\/JVI.73.11.9468-9477.1999","article-title":"Concatamerization of adeno-associated virus circular genomes occurs through intermolecular recombination","volume":"73","author":"Yang","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib91","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcb.21819","article-title":"Adeno-associated virus-mediated gene transfer","volume":"105","author":"Srivastava","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.cjca.2011.02.005_bib92","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cardfail.2009.01.013","article-title":"Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1\/2 clinical trial","volume":"15","author":"Jaski","year":"2009","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2011.02.005_bib93","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ymthe.2006.05.004","article-title":"Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B","volume":"14","author":"Jiang","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib94","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0904514106","article-title":"Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy","volume":"106","author":"Brantly","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib95","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(09)61836-5","article-title":"Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial","volume":"374","author":"Maguire","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2011.02.005_bib96","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/mt.2010.106","article-title":"Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC","volume":"18","author":"Hadaczek","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib97","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy","volume":"113","author":"Niemeyer","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2011.02.005_bib98","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ymthe.2005.11.007","article-title":"AAV transcytosis through barrier epithelia and endothelium","volume":"13","author":"Di Pasquale","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-59745-210-6_2","article-title":"The role of the adeno-associated virus capsid in gene transfer","volume":"437","author":"Van Vliet","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cjca.2011.02.005_bib100","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1128\/JVI.00878-06","article-title":"The 37\/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9","volume":"80","author":"Akache","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib101","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1128\/JVI.79.1.609-614.2005","article-title":"Hepatocyte growth factor receptor is a coreceptor for adeno-associated virus type 2 infection","volume":"79","author":"Kashiwakura","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib102","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/4758","article-title":"Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2","volume":"5","author":"Qing","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib103","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1128\/JVI.75.15.6884-6893.2001","article-title":"Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity","volume":"75","author":"Kaludov","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib104","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/4768","article-title":"AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection","volume":"5","author":"Summerford","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib105","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm929","article-title":"Identification of PDGFR as a receptor for AAV-5 transduction","volume":"9","author":"Di Pasquale","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib106","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1089\/hum.2006.17.10","article-title":"Adeno-associated virus types 5 and 6 use distinct receptors for cell entry","volume":"17","author":"Seiler","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib107","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1161\/01.RES.0000237661.18885.f6","article-title":"Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo","volume":"99","author":"Pacak","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib108","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2008.76","article-title":"Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection","volume":"16","author":"Zincarelli","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib109","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jor.20781","article-title":"Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin\/utrophin-deficient mice","volume":"27","author":"Wang","year":"2009","journal-title":"J Orthop Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib110","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/hum.2008.123","article-title":"Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat","volume":"19","author":"Bish","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/gt.2010.105","article-title":"Robust cardiomyocyte-specific gene expression following systemic injection of AAV: in vivo gene delivery follows a Poisson distribution","volume":"18","author":"Prasad","year":"2011","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib112","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nbt1073","article-title":"Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart","volume":"23","author":"Wang","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cjca.2011.02.005_bib113","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.gt.3302895","article-title":"Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo","volume":"14","author":"Palomeque","year":"2007","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib114","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/gt.2008.111","article-title":"Augmentation of AAV-mediated cardiac gene transfer after systemic administration in adult rats","volume":"15","author":"Muller","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib115","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1038\/mt.2008.207","article-title":"A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs","volume":"16","author":"Yue","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib116","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ymthe.2004.07.016","article-title":"Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6","volume":"10","author":"Blankinship","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib117","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/mt.2009.116","article-title":"Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature","volume":"17","author":"Gregorevic","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib118","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/mt.2010.77","article-title":"SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells","volume":"18","author":"Hadri","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib119","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jacc.2007.12.014","article-title":"Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure","volume":"51","author":"Kawase","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jgm.1129","article-title":"AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid","volume":"10","author":"Su","year":"2008","journal-title":"J Gene Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib121","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/sj.gt.3303035","article-title":"Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors","volume":"15","author":"Raake","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib122","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1152\/physiolgenomics.00254.2005","article-title":"Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation","volume":"25","author":"Wu","year":"2006","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.cjca.2011.02.005_bib123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nbt.1599","article-title":"Reengineering a receptor footprint of adeno-associated virus enables selective and systemic gene transfer to muscle","volume":"28","author":"Asokan","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cjca.2011.02.005_bib124","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mt.2009.292","article-title":"Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB)","volume":"18","author":"Gray","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib125","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/mt.2008.167","article-title":"DNA shuffling of adeno-associated virus yields functionally diverse viral progeny","volume":"16","author":"Koerber","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib126","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/mt.2008.100","article-title":"Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticles","volume":"16","author":"Li","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib127","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/gt.2010.44","article-title":"Heart-targeted adeno-associated viral vectors selected by in vivo biopanning of a random viral display peptide library","volume":"17","author":"Ying","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib128","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0008-6363(97)00154-5","article-title":"Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters","volume":"35","author":"Franz","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib129","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/hy0202.103472","article-title":"Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection","volume":"39","author":"Phillips","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2011.02.005_bib130","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/sj.gt.3302787","article-title":"AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect","volume":"13","author":"Su","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib131","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-0556-6-13","article-title":"Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice","volume":"6","author":"Pacak","year":"2008","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib132","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/sj.mt.6300027","article-title":"Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle","volume":"15","author":"Salva","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib133","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/mt.2008.288","article-title":"MicroRNAs and the regulation of vector tropism","volume":"17","author":"Kelly","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib134","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/mt.2008.159","article-title":"miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy","volume":"16","author":"Suzuki","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/mthe.2001.0456","article-title":"Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison","volume":"4","author":"Duan","year":"2001","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib136","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-59745-237-3_16","article-title":"Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy","volume":"433","author":"Lai","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.cjca.2011.02.005_bib137","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1153","article-title":"Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors","volume":"23","author":"Lai","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cjca.2011.02.005_bib138","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/75087","article-title":"Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization","volume":"6","author":"Sun","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib139","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1161\/01.CIR.0000096487.88897.9B","article-title":"Robust adenoviral and adeno-associated viral gene transfer to the in vivo murine heart: application to study of phospholamban physiology","volume":"108","author":"Champion","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib140","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/mt.2008.171","article-title":"Self-complementary AAV vectors; advances and applications","volume":"16","author":"McCarty","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib141","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","article-title":"Integration of adeno-associated virus (AAV) and recombinant AAV vectors","volume":"38","author":"McCarty","year":"2004","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.cjca.2011.02.005_bib142","doi-asserted-by":"crossref","first-page":"11304","DOI":"10.1128\/JVI.01225-07","article-title":"The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice","volume":"81","author":"Inagaki","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib143","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1126\/science.1142658","article-title":"AAV vector integration sites in mouse hepatocellular carcinoma","volume":"317","author":"Donsante","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.cjca.2011.02.005_bib144","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ymthe.2006.03.008","article-title":"Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver","volume":"14","author":"Bell","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymthe.2005.03.020","article-title":"No evidence for tumorigenesis of AAV vectors in a large-scale study in mice","volume":"12","author":"Bell","year":"2005","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib146","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cjca.2011.02.005_bib147","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1099\/vir.0.014175-0","article-title":"Adeno-associated virus serotype 2 induces cell-mediated immune responses directed against multiple epitopes of the capsid protein VP1","volume":"90","author":"Madsen","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib148","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib149","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/gt.2008.71","article-title":"AAV-mediated gene transfer for the treatment of hemophilia B: problems and prospects","volume":"15","author":"Hasbrouck","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2174\/156652307782151425","article-title":"Immune responses to AAV in clinical trials","volume":"7","author":"Mingozzi","year":"2007","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib151","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nm1549","article-title":"CD8(+) T-cell responses to adeno-associated virus capsid in humans","volume":"13","author":"Mingozzi","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib152","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/mt.2009.301","article-title":"BALB\/c mice show impaired hepatic tolerogenic response following AAV gene transfer to the liver","volume":"18","author":"Breous","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib153","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.4049\/jimmunol.0803965","article-title":"Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteins","volume":"182","author":"Mays","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.cjca.2011.02.005_bib154","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1128\/JVI.00529-07","article-title":"Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo","volume":"81","author":"Li","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.cjca.2011.02.005_bib155","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/mt.2010.40","article-title":"AAV vectors avoid inflammatory signals necessary to render transduced hepatocyte targets for destructive T cells","volume":"18","author":"Somanathan","year":"2010","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib156","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.mt.6300123","article-title":"Immune responses to AAV capsid: are mice not humans after all?","volume":"15","author":"Herzog","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib157","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/gt.2008.54","article-title":"Immunity to adeno-associated virus vectors in animals and humans: a continued challenge","volume":"15","author":"Zaiss","year":"2008","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib158","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/mt.2009.150","article-title":"Strategies to modulate immune responses: a new frontier for gene therapy","volume":"17","author":"Arruda","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib159","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/gt.2008.170","article-title":"Tailoring the AAV vector capsid for gene therapy","volume":"16","author":"Vandenberghe","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib160","first-page":"493","article-title":"Evading the immune response upon in vivo gene therapy with viral vectors","volume":"11","author":"Sack","year":"2009","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib161","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/hum.2004.15.989","article-title":"Nitroprusside increases gene transfer associated with intracoronary delivery of adenovirus","volume":"15","author":"Roth","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib162","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1073\/pnas.0813207106","article-title":"A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection","volume":"106","author":"Yang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib163","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1161\/01.CIR.90.5.2414","article-title":"Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors","volume":"90","author":"French","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib164","first-page":"392","article-title":"Incomplete retention after direct myocardial injection","volume":"55","author":"Grossman","year":"2002","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cjca.2011.02.005_bib165","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0735-1097(00)00522-2","article-title":"Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat\u2014angiogenesis and angioma formation","volume":"35","author":"Schwarz","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib166","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/sj.gt.3301614","article-title":"In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo","volume":"8","author":"Wright","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib167","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/mt.2008.202","article-title":"Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines","volume":"16","author":"Bish","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib168","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1124\/dmd.104.002774","article-title":"Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution","volume":"33","author":"Laham","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.cjca.2011.02.005_bib169","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0735-1097(99)00642-7","article-title":"Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy","volume":"35","author":"Kornowski","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib170","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.gt.3302477","article-title":"Efficient, cardiac-specific adenoviral gene transfer in rat heart by isolated retrograde perfusion in vivo","volume":"12","author":"O'Donnell","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib171","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/mt.2008.225","article-title":"Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle","volume":"17","author":"Ohshima","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib172","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/hc1102.105595","article-title":"Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris","volume":"105","author":"Grines","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib173","doi-asserted-by":"crossref","first-page":"I157","DOI":"10.1161\/01.CIRCULATIONAHA.105.525782","volume":"112","author":"Gyongyosi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib174","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.98.25.2800","article-title":"Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia","volume":"98","author":"Losordo","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib175","first-page":"H310","article-title":"Intrapericardial administration of adenovirus for gene transfer","volume":"272","author":"Lamping","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib176","doi-asserted-by":"crossref","first-page":"I23","DOI":"10.1002\/clc.4960221308","article-title":"Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors","volume":"22","author":"March","year":"1999","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib177","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.gt.3300853","article-title":"Gene delivery to the myocardium by intrapericardial injection","volume":"6","author":"Fromes","year":"1999","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib178","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/82214","article-title":"Focal modification of electrical conduction in the heart by viral gene transfer","volume":"6","author":"Donahue","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib179","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.cardiores.2006.09.021","article-title":"Targeting the heart with gene therapy-optimized gene delivery methods","volume":"73","author":"Muller","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib180","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1073\/pnas.95.9.5251","article-title":"Modulation of ventricular function through gene transfer in vivo","volume":"95","author":"Hajjar","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib181","doi-asserted-by":"crossref","first-page":"H2995","DOI":"10.1152\/ajpheart.00703.2004","article-title":"Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade","volume":"288","author":"Hayase","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib182","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/hc0402.102953","article-title":"Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer","volume":"105","author":"Ikeda","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib183","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jtcvs.2005.07.035","article-title":"Efficient myocyte gene delivery with complete cardiac surgical isolation in situ","volume":"130","author":"Bridges","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2011.02.005_bib184","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/01.CIR.104.2.131","article-title":"Cardiac gene delivery with cardiopulmonary bypass","volume":"104","author":"Davidson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib185","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1010-7940(02)00078-7","article-title":"Adenoviral gene transfer to the heart during cardiopulmonary bypass: effect of myocardial protection technique on transgene expression","volume":"21","author":"Jones","year":"2002","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2011.02.005_bib186","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ejcts.2004.08.028","article-title":"Beta2 adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery","volume":"26","author":"Jones","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2011.02.005_bib187","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jacc.2004.05.074","article-title":"Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery","volume":"44","author":"Raake","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib188","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.gt.3301079","article-title":"Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins","volume":"7","author":"Boekstegers","year":"2000","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib189","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1089\/10430340152528101","article-title":"How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures?","volume":"12","author":"Logeart","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib190","doi-asserted-by":"crossref","first-page":"H1773","DOI":"10.1152\/ajpheart.00411.2006","article-title":"Percutaneous intracoronary delivery of SERCA gene increases myocardial function: a tissue Doppler imaging echocardiographic study","volume":"291","author":"Logeart","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib191","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1525-0016(03)00149-7","article-title":"Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate","volume":"8","author":"Emani","year":"2003","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib192","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cardfail.2008.02.005","article-title":"Design of a phase 1\/2 trial of intracoronary administration of AAV1\/SERCA2a in patients with heart failure","volume":"14","author":"Hajjar","year":"2008","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2011.02.005_bib193","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1161\/01.CIR.0000035240.92015.E4","article-title":"New efficient catheter-based system for myocardial gene delivery","volume":"106","author":"Beeri","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib194","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.gt.3302748","article-title":"Gene therapy, angiogenesis, Sonic Hedgehog: Sonic the Hedgehog to the rescue?","volume":"13","author":"Donahue","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib195","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/sj.gt.3300649","article-title":"Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin","volume":"5","author":"Donahue","year":"1998","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib196","first-page":"H2735","article-title":"VEGF induces NO-dependent hyperpermeability in coronary venules","volume":"271","author":"Wu","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib197","doi-asserted-by":"crossref","first-page":"H172","DOI":"10.1152\/ajpheart.01009.2003","article-title":"Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice","volume":"287","author":"Roth","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib198","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCRESAHA.109.200386","article-title":"Human studies of angiogenic gene therapy","volume":"105","author":"Gupta","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib199","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2004.05291.x","article-title":"The crucial role of vascular permeability factor\/vascular endothelial growth factor in angiogenesis: a historical review","volume":"128","author":"Ribatti","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cjca.2011.02.005_bib200","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/380435a0","article-title":"Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele","volume":"380","author":"Carmeliet","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.cjca.2011.02.005_bib201","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00041552-199601000-00008","article-title":"Vascular endothelial growth factor, a specific regulator of angiogenesis","volume":"5","author":"Ferrara","year":"1996","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.cjca.2011.02.005_bib202","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/hrt.2009.180414","article-title":"Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects","volume":"97","author":"Zachary","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2011.02.005_bib203","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/CIRCULATIONAHA.105.535294","article-title":"Role of angiogenesis in cardiovascular disease: a critical appraisal","volume":"112","author":"Khurana","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib204","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00063030-200822040-00001","article-title":"Pro-angiogenic cytokines as cardiovascular therapeutics: assessing the potential","volume":"22","author":"Atluri","year":"2008","journal-title":"BioDrugs"},{"key":"10.1016\/j.cjca.2011.02.005_bib205","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1161\/01.CIR.0000070540.80780.92","volume":"107","author":"Hedman","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib206","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/10430340050016003","article-title":"Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty","volume":"11","author":"Laitinen","year":"2000","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib207","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/gt.2009.4","article-title":"Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer","volume":"16","author":"Hedman","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib208","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/sj.gt.3302802","article-title":"Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment","volume":"13","author":"Stewart","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib209","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/mt.2009.70","article-title":"VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial","volume":"17","author":"Stewart","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib210","doi-asserted-by":"crossref","first-page":"C1148","DOI":"10.1152\/ajpcell.1999.276.5.C1148","article-title":"VEGF increases permeability of the blood-brain barrier via a nitric oxide synthase\/cGMP-dependent pathway","volume":"276","author":"Mayhan","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib211","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/01.CIR.0000093398.16124.29","volume":"108","author":"Rajagopalan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0b013e3282f97d98","article-title":"Fibroblast growth factor regulation of neovascularization","volume":"15","author":"Murakami","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.cjca.2011.02.005_bib213","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.bjp.0705493","article-title":"Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF-2)","volume":"140","author":"Aviles","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cjca.2011.02.005_bib214","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2007.06.010","article-title":"Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials","volume":"50","author":"Henry","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tcm.2008.03.002","article-title":"Fibroblast growth factor 4 gene therapy for chronic ischemic heart disease","volume":"18","author":"Kapur","year":"2008","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib216","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/mt.2008.33","article-title":"Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia","volume":"16","author":"Nikol","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib217","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/01.HYP.0000136394.08900.ed","article-title":"Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease","volume":"44","author":"Morishita","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.cjca.2011.02.005_bib218","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1161\/01.CIR.100.23.2308","article-title":"Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a","volume":"100","author":"del Monte","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib219","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2353\/ajpath.2007.070054","article-title":"Mutation of delta-sarcoglycan is associated with Ca(2+)-dependent vascular remodeling in the Syrian hamster","volume":"171","author":"Lipskaia","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.cjca.2011.02.005_bib220","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1096\/fj.04-3633fje","article-title":"Regulation of store-operated calcium entries and mitochondrial uptake by minidystrophin expression in cultured myotubes","volume":"20","author":"Vandebrouck","year":"2006","journal-title":"FASEB J"},{"key":"10.1016\/j.cjca.2011.02.005_bib221","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/ncpcardio1301","article-title":"The cardiac sarcoplasmic\/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases","volume":"5","author":"Kawase","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib222","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cvr\/cvm009","article-title":"The sarcoplasmic reticulum and arrhythmogenic calcium release","volume":"77","author":"Venetucci","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib223","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cardiores.2007.02.006","article-title":"Calcium waves driven by \u201csensitization\u201d wave-fronts","volume":"74","author":"Keller","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib224","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/jmcc.2001.1368","article-title":"SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes","volume":"33","author":"Davia","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib225","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fj.02-0474fje","article-title":"Cardiac-specific overexpression of a high Ca2+ affinity mutant of SERCA2a attenuates in vivo pressure overload cardiac hypertrophy","volume":"17","author":"Nakayama","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.cjca.2011.02.005_bib226","doi-asserted-by":"crossref","first-page":"H1204","DOI":"10.1152\/ajpheart.00892.2006","article-title":"Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model","volume":"292","author":"Sakata","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib227","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.RES.0000180663.42594.aa","article-title":"Sarco\/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat","volume":"97","author":"Lipskaia","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib228","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/CIRCRESAHA.108.172031","article-title":"Endothelial S100A1 modulates vascular function via nitric oxide","volume":"102","author":"Pleger","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib229","first-page":"E65","article-title":"Transcoronary gene transfer of SERCA2a increases coronary blood flow trought an increase of eNOS activity in endothelial cells","volume":"101","author":"Hadri","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib230","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2007.03.047","article-title":"Percutaneous cardiac recirculation-mediated gene transfer of an inhibitory phospholamban peptide reverses advanced heart failure in large animals","volume":"50","author":"Kaye","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib231","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1161\/CIRCULATIONAHA.108.783852","article-title":"Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy","volume":"119","author":"Suckau","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib232","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.yjmcc.2009.05.010","article-title":"Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology","volume":"47","author":"Nicolaou","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib233","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/01.RES.0000161256.85833.fa","article-title":"Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1","volume":"96","author":"Pathak","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib234","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/CIRCRESAHA.108.189811","article-title":"Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia\/reperfusion injury","volume":"104","author":"Nicolaou","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib235","first-page":"30","article-title":"Key protein alterations associated with hyperdynamic cardiac function: insights based on proteomic analysis of the protein phosphatase 1 inhibitor-1 overexpressing hearts","volume":"48","author":"Pathak","year":"2007","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib236","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1128\/MCB.22.8.2821-2829.2002","article-title":"Impaired cardiac contractility response to hemodynamic stress in S100A1-deficient mice","volume":"22","author":"Du","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.cjca.2011.02.005_bib237","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/CIRCULATIONAHA.106.671701","article-title":"Stable myocardial-specific AAV6-S100A1 gene therapy results in chronic functional heart failure rescue","volume":"115","author":"Pleger","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib238","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cardfail.2007.01.003","article-title":"Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy","volume":"13","author":"Pleger","year":"2007","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2011.02.005_bib239","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10741-008-9132-8","article-title":"Beta-adrenergic stimulation and myocardial function in the failing heart","volume":"14","author":"El-Armouche","year":"2009","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2011.02.005_bib240","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1586\/14779072.5.1.119","article-title":"Beta-adrenergic pathways in human heart failure","volume":"5","author":"Sucharov","year":"2007","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib241","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1254\/jphs.CRJ06001X","article-title":"Cardiac adrenoceptors: physiological and pathophysiological relevance","volume":"100","author":"Brodde","year":"2006","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.cjca.2011.02.005_bib242","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1080\/AC.65.5.2056244","article-title":"Beta-blockers: focus on mechanism of action","volume":"65","author":"Gorre","year":"2010","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib243","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/107424840400900404","article-title":"Beta-adrenergic blockers in heart failure: review of mechanisms of action and clinical outcomes","volume":"9","author":"Satwani","year":"2004","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib244","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1161\/01.CIR.101.1.71","article-title":"beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis","volume":"101","author":"Du","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib245","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.8160017","article-title":"Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor","volume":"264","author":"Milano","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.cjca.2011.02.005_bib246","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1067\/mtc.2000.107519","article-title":"Adenovirus-mediated genetic manipulation of the myocardial beta-adrenergic signaling system in transplanted hearts","volume":"120","author":"Shah","year":"2000","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2011.02.005_bib247","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1073\/pnas.96.11.6400","article-title":"Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice","volume":"96","author":"Dorn","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cjca.2011.02.005_bib248","doi-asserted-by":"crossref","DOI":"10.1007\/s00424-007-0324-1","article-title":"Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors\u2014what can we learn for the therapy of heart failure?","volume":"455","author":"Lee","year":"2008","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.cjca.2011.02.005_bib249","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000028397","article-title":"Pharmacogenetics of beta-1- and beta-2-adrenergic receptors","volume":"61","author":"Liggett","year":"2000","journal-title":"Pharmacology"},{"key":"10.1016\/j.cjca.2011.02.005_bib250","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00109-009-0450-7","article-title":"GRK mythology: G-protein receptor kinases in cardiovascular disease","volume":"87","author":"Dorn","year":"2009","journal-title":"J Mol Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib251","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1476-5381.2010.00727.x","article-title":"The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets","volume":"160","author":"Penela","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.cjca.2011.02.005_bib252","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejphar.2004.03.015","article-title":"Differential functional expression of human myocardial G protein receptor kinases in left ventricular cardiac diseases","volume":"489","author":"Dzimiri","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.cjca.2011.02.005_bib253","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cardiores.2005.01.025","article-title":"G-protein-coupled receptor kinase activity in human heart failure: effects of beta-adrenoceptor blockade","volume":"66","author":"Leineweber","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib254","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cardiores.2005.09.011","article-title":"Mechanisms of regulation of G protein-coupled receptor kinases (GRKs) and cardiovascular disease","volume":"69","author":"Penela","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib255","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.cardiores.2003.09.014","article-title":"Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure","volume":"60","author":"El-Armouche","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib256","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tcm.2007.07.001","article-title":"New signaling pathways associated with increased cardiac adenylyl cyclase 6 expression: implications for possible congestive heart failure therapy","volume":"17","author":"Phan","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib257","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1253\/circj.CJ-08-0957","article-title":"Adenylyl cyclase type 5 disruption prolongs longevity and protects the heart against stress","volume":"73","author":"Vatner","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.cjca.2011.02.005_bib258","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1196\/annals.1380.032","article-title":"Adenylyl cyclase gene transfer in heart failure","volume":"1080","author":"Hammond","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.cjca.2011.02.005_bib259","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1152\/physrev.00032.2006","article-title":"Cardiac myocyte cell cycle control in development, disease, and regeneration","volume":"87","author":"Ahuja","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.cjca.2011.02.005_bib260","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1753944709336190","article-title":"A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart","volume":"3","author":"Stamm","year":"2009","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2011.02.005_bib261","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cvr\/cvn026","article-title":"Divide to survive: myocardial regeneration and functional recovery after cell cycle activation in injured hearts","volume":"78","author":"Costa","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib262","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yexcr.2004.10.022","article-title":"Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy","volume":"304","author":"Busk","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib263","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1161\/CIRCRESAHA.107.153544","article-title":"Cyclin A2 induces cardiac regeneration after myocardial infarction and prevents heart failure","volume":"100","author":"Cheng","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib264","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cvr\/cvm101","article-title":"Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction","volume":"78","author":"Hassink","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib265","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000152326.91223.4F","article-title":"Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice","volume":"96","author":"Pasumarthi","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib266","doi-asserted-by":"crossref","first-page":"I206","DOI":"10.1161\/CIRCULATIONAHA.105.000455","article-title":"Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure","volume":"114","author":"Woo","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2011.02.005_bib267","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00246-009-9408-3","article-title":"Cell-cycle-based strategies to drive myocardial repair","volume":"30","author":"Zhu","year":"2009","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib268","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14737159.3.5.617","article-title":"E- and A-type cyclins as markers for cancer diagnosis and prognosis","volume":"3","author":"Yasmeen","year":"2003","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.cjca.2011.02.005_bib269","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jtcvs.2007.10.024","article-title":"Cardiac stem cells in the real world","volume":"135","author":"Pouly","year":"2008","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cjca.2011.02.005_bib270","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.RES.0000135902.99383.6f","article-title":"Mesenchymal stem cells and their potential as cardiac therapeutics","volume":"95","author":"Pittenger","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib271","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2010.211","article-title":"Mesenchymal stem cells for cardiac cell therapy","volume":"22","author":"Choi","year":"2011","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib272","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm912","article-title":"Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts","volume":"9","author":"Mangi","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.cjca.2011.02.005_bib273","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3760\/cma.j.issn.0366-6999.2010.13.017","article-title":"AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium","volume":"123","author":"Yu","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.cjca.2011.02.005_bib274","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1093\/eurjhf\/hfp135","article-title":"Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction","volume":"11","author":"Fan","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2011.02.005_bib275","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1634\/stemcells.2006-0771","article-title":"Bcl-2 engineered MSCs inhibited apoptosis and improved heart function","volume":"25","author":"Li","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.cjca.2011.02.005_bib276","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.mt.6300374","article-title":"Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance","volume":"16","author":"Cheng","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.cjca.2011.02.005_bib277","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ejcts.2009.04.052","article-title":"Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats","volume":"36","author":"Tang","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2011.02.005_bib278","first-page":"891","article-title":"A promising strategy for the treatment of ischemic heart disease: mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats","volume":"23","author":"Gao","year":"2007","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib279","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1016\/j.yexcr.2009.09.026","article-title":"Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K\/Akt pathway","volume":"315","author":"Tang","year":"2009","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11010-009-0374-0","article-title":"Combination of chemokine and angiogenic factor genes and mesenchymal stem cells could enhance angiogenesis and improve cardiac function after acute myocardial infarction in rats","volume":"339","author":"Tang","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cjca.2011.02.005_bib281","doi-asserted-by":"crossref","first-page":"e9943","DOI":"10.1371\/journal.pone.0009943","article-title":"Cardiogenic induction of pluripotent stem cells streamlined through a conserved SDF-1\/VEGF\/BMP2 integrated network","volume":"5","author":"Chiriac","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.cjca.2011.02.005_bib282","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s12265-010-9219-1","article-title":"SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells","volume":"3","author":"Chiriac","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib283","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1510\/icvts.2007.169896","article-title":"Adenovirus-mediated stromal cell-derived-factor-1alpha gene transfer induces cardiac preservation after infarction via angiogenesis of CD133+ stem cells and anti-apoptosis","volume":"7","author":"Tang","year":"2008","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.cjca.2011.02.005_bib285","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cvr\/cvq301","article-title":"G-CSF for stem cell therapy in acute myocardial infarction: friend or foe?","volume":"89","author":"Shim","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib286","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehq475","article-title":"Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair","author":"Fujii","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2011.02.005_bib287","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nrcardio.2010.159","article-title":"Induced pluripotent stem cells: developmental biology to regenerative medicine","volume":"7","author":"Nelson","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib288","first-page":"29","article-title":"Induced pluripotent stem cells: advances to applications","volume":"3","author":"Nelson","year":"2010","journal-title":"Stem Cells Cloning"},{"key":"10.1016\/j.cjca.2011.02.005_bib289","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/cell.2009.0077","article-title":"Amniotic fluid cells are more efficiently reprogrammed to pluripotency than adult cells","volume":"12","author":"Galende","year":"2010","journal-title":"Cell Reprogram"},{"key":"10.1016\/j.cjca.2011.02.005_bib290","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/scd.2009.0149","article-title":"Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells","volume":"19","author":"Kunisato","year":"2010","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.cjca.2011.02.005_bib291","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1161\/CIRCRESAHA.109.203109","article-title":"iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism","volume":"105","author":"Martinez-Fernandez","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.cjca.2011.02.005_bib292","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1752-8062.2009.00091.x","article-title":"Induced pluripotent reprogramming from promiscuous human stemness related factors","volume":"2","author":"Nelson","year":"2009","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.cjca.2011.02.005_bib293","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.yjmcc.2010.10.026","article-title":"iPS cells: A source of cardiac regeneration","volume":"50","author":"Yoshida","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.cjca.2011.02.005_bib294","author":"Hammond"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1100167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X1100167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:35:11Z","timestamp":1760106911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X1100167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":291,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0828282X1100167X"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2011.02.005","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Gene Therapy for the Treatment of Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2011.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}